global view constructed of white lines

Blog

Howard R Krauss MD Headshot
November 29, 2020

Howard R. Krauss, MD, elected Vice President of the Medical Board of California

by Zara Jethani

Howard R. Krauss, MD, has been elected Vice President of the Medical Board of California, reported in an official state announcement released November 13, 2020. In his role, he will, in collaboration with the President, and as a member of the Executive Committee, oversee various...

Think Neuro Podcast The Promise of Psychedelics with Dr. Keith Heinzerling & Louie Schwartzberg
November 18, 2020

The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg

by Anthony Effinger

Addiction and depression are two of the most widespread conditions in all of medicine. After decades of research, doctors are still looking for alternatives for when medication and cognitive training don’t work, which is all too often.

Kesimpta for Multiple Sclerosis
November 15, 2020

Multiple Sclerosis – A New Treatment, A New Hope

by Guest Author

A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....

Learning an instrument during COVID
November 8, 2020

Optimizing Brain Health During COVID

by William Buxton

As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.

November Clinical Trials at PNI
November 2, 2020

Clinical Trials Round-Up: November 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Last updated: November 17th, 2020